Immune outposts inside kidney tumors predict post-surgery outcomes

Patients with well-supported immune cells in their tumors are more likely to control their cancers’ growth for a longer time, an observation that could guide treatment decisions after surgery for kidney cancer. In addition, the findings could help researchers expand the dramatic but sparse benefits of cancer immunotherapy to more people.

Share this post:


 

Related Posts